Pancreatic Cancer Research

ResearcherCentral South UniversityNo recent work listed

Bo Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4526-714X; OpenAlex author ID A5100673885. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 2

  1. GBP2 as a potential prognostic biomarker in pancreatic adenocarcinoma. Co-author DOI 10.7717/peerj.11423↗
  2. MicroRNA-145 suppresses cell proliferation, invasion and migration in pancreatic cancer cells by targeting NEDD9. Co-author DOI 10.3892/mmr.2015.3294↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tao Ren · 1 shared paper, 2021 · strength 0.14
  2. Wei Zhou · 1 shared paper, 2021 · strength 0.14
  3. Ke Xu · 1 shared paper, 2021 · strength 0.14
  4. Chengyou Du · 1 shared paper, 2021 · strength 0.14
  5. LI Yi-xiong · 1 shared paper, 2015 · strength 0.06
  6. Mujing Ke · 1 shared paper, 2015 · strength 0.06
  7. Xiaoping Yi · 1 shared paper, 2015 · strength 0.06
  8. Tong Han · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.